Concepts (217)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Histiocytosis, Langerhans-Cell | 3 | 2015 | 231 | 0.470 |
Why?
|
| Colitis | 2 | 2024 | 159 | 0.340 |
Why?
|
| Neoplasms, Second Primary | 2 | 2014 | 143 | 0.340 |
Why?
|
| Langerhans Cells | 2 | 2015 | 21 | 0.330 |
Why?
|
| Eosinophilic Esophagitis | 3 | 2016 | 77 | 0.300 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2014 | 530 | 0.270 |
Why?
|
| Cephalexin | 1 | 2006 | 7 | 0.260 |
Why?
|
| Loss of Heterozygosity | 1 | 2007 | 124 | 0.250 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2007 | 199 | 0.240 |
Why?
|
| Drug Hypersensitivity | 1 | 2006 | 97 | 0.230 |
Why?
|
| Myocarditis | 1 | 2006 | 130 | 0.230 |
Why?
|
| Myofibromatosis | 1 | 2025 | 10 | 0.220 |
Why?
|
| Genetic Markers | 1 | 2007 | 605 | 0.220 |
Why?
|
| Mannose-Binding Lectins | 1 | 2004 | 26 | 0.220 |
Why?
|
| Lectins, C-Type | 1 | 2004 | 69 | 0.220 |
Why?
|
| Alcoholic Beverages | 1 | 2004 | 17 | 0.220 |
Why?
|
| Antigens, Surface | 1 | 2004 | 116 | 0.210 |
Why?
|
| Alcoholic Intoxication | 1 | 2004 | 13 | 0.210 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2008 | 758 | 0.180 |
Why?
|
| Testicular Neoplasms | 2 | 2017 | 123 | 0.180 |
Why?
|
| Oncostatin M Receptor beta Subunit | 1 | 2021 | 1 | 0.180 |
Why?
|
| Oncostatin M | 1 | 2021 | 4 | 0.180 |
Why?
|
| Yttrium Radioisotopes | 1 | 2020 | 27 | 0.160 |
Why?
|
| Embolization, Therapeutic | 2 | 2020 | 223 | 0.150 |
Why?
|
| Hepatoblastoma | 1 | 2020 | 187 | 0.140 |
Why?
|
| Testicular Diseases | 1 | 2017 | 12 | 0.130 |
Why?
|
| Calculi | 1 | 2017 | 15 | 0.130 |
Why?
|
| Behcet Syndrome | 1 | 2017 | 14 | 0.130 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2021 | 328 | 0.130 |
Why?
|
| Receptors, Interleukin-7 | 1 | 2016 | 27 | 0.120 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2016 | 15 | 0.120 |
Why?
|
| Immunoglobulin E | 2 | 2014 | 225 | 0.120 |
Why?
|
| Child | 15 | 2021 | 26239 | 0.120 |
Why?
|
| Venous Thrombosis | 1 | 2017 | 168 | 0.120 |
Why?
|
| Child, Preschool | 9 | 2020 | 15047 | 0.110 |
Why?
|
| Urinary Bladder | 2 | 2014 | 249 | 0.110 |
Why?
|
| Thymus Hyperplasia | 1 | 2015 | 1 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 1 | 2006 | 2566 | 0.110 |
Why?
|
| Thymus Gland | 1 | 2015 | 102 | 0.110 |
Why?
|
| Humans | 29 | 2025 | 131504 | 0.110 |
Why?
|
| Ganglioglioma | 1 | 2014 | 21 | 0.110 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 156 | 0.110 |
Why?
|
| Lipoma | 1 | 2014 | 25 | 0.110 |
Why?
|
| Fasciitis | 1 | 2014 | 18 | 0.110 |
Why?
|
| Polycystic Kidney Diseases | 1 | 2014 | 32 | 0.100 |
Why?
|
| Fibroma | 1 | 2014 | 29 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2014 | 102 | 0.100 |
Why?
|
| Rhabdoid Tumor | 1 | 2014 | 48 | 0.100 |
Why?
|
| Joint Diseases | 1 | 2014 | 32 | 0.100 |
Why?
|
| Arthroscopy | 1 | 2014 | 49 | 0.100 |
Why?
|
| Mydriasis | 1 | 2013 | 8 | 0.100 |
Why?
|
| Basophils | 1 | 2013 | 14 | 0.100 |
Why?
|
| Intestinal Pseudo-Obstruction | 1 | 2013 | 30 | 0.100 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2013 | 31 | 0.100 |
Why?
|
| Ribonuclease III | 1 | 2014 | 103 | 0.100 |
Why?
|
| Muscle, Smooth | 1 | 2013 | 129 | 0.100 |
Why?
|
| Cytokines | 3 | 2016 | 1347 | 0.100 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 588 | 0.100 |
Why?
|
| Knee Joint | 1 | 2014 | 173 | 0.100 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2014 | 162 | 0.100 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2014 | 205 | 0.090 |
Why?
|
| Wilms Tumor | 1 | 2014 | 120 | 0.090 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2014 | 128 | 0.090 |
Why?
|
| Autophagy | 1 | 2016 | 424 | 0.090 |
Why?
|
| Polyradiculopathy | 1 | 2012 | 2 | 0.090 |
Why?
|
| Low Back Pain | 1 | 2012 | 39 | 0.090 |
Why?
|
| Male | 17 | 2025 | 65158 | 0.090 |
Why?
|
| Spinal Neoplasms | 1 | 2012 | 74 | 0.090 |
Why?
|
| Sarcoma | 1 | 2014 | 210 | 0.090 |
Why?
|
| Antitubercular Agents | 1 | 2013 | 264 | 0.090 |
Why?
|
| Orbital Pseudotumor | 1 | 2011 | 8 | 0.090 |
Why?
|
| Chromosome Deletion | 1 | 2014 | 650 | 0.080 |
Why?
|
| Hemangioma | 1 | 2012 | 92 | 0.080 |
Why?
|
| Signal Transduction | 2 | 2016 | 4674 | 0.080 |
Why?
|
| Cellulitis | 1 | 2011 | 62 | 0.080 |
Why?
|
| Colon | 1 | 2013 | 360 | 0.080 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2011 | 58 | 0.080 |
Why?
|
| Proteins | 1 | 2016 | 1025 | 0.080 |
Why?
|
| Food Hypersensitivity | 1 | 2014 | 184 | 0.080 |
Why?
|
| Blindness | 1 | 2011 | 72 | 0.080 |
Why?
|
| Phosphotransferases | 1 | 2010 | 33 | 0.080 |
Why?
|
| Teratoma | 1 | 2011 | 124 | 0.080 |
Why?
|
| Anti-HIV Agents | 1 | 2013 | 359 | 0.080 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 1386 | 0.080 |
Why?
|
| Infant, Newborn | 4 | 2025 | 8589 | 0.080 |
Why?
|
| Kidney Neoplasms | 1 | 2014 | 454 | 0.080 |
Why?
|
| Mutation, Missense | 1 | 2014 | 929 | 0.070 |
Why?
|
| Adolescent | 9 | 2017 | 20917 | 0.070 |
Why?
|
| Mesentery | 1 | 2009 | 27 | 0.070 |
Why?
|
| Infant | 6 | 2015 | 13300 | 0.070 |
Why?
|
| Myeloproliferative Disorders | 1 | 2010 | 92 | 0.070 |
Why?
|
| Frameshift Mutation | 1 | 2010 | 202 | 0.070 |
Why?
|
| Janus Kinase 2 | 1 | 2010 | 139 | 0.070 |
Why?
|
| Intestinal Volvulus | 1 | 2009 | 39 | 0.070 |
Why?
|
| Female | 14 | 2020 | 71087 | 0.070 |
Why?
|
| Peritoneal Neoplasms | 1 | 2009 | 56 | 0.070 |
Why?
|
| Acute Disease | 2 | 2012 | 1153 | 0.070 |
Why?
|
| Intestinal Obstruction | 1 | 2009 | 86 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2014 | 3911 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2015 | 2464 | 0.070 |
Why?
|
| Autoimmune Diseases | 1 | 2010 | 275 | 0.070 |
Why?
|
| Methotrexate | 2 | 2025 | 342 | 0.070 |
Why?
|
| Tuberculosis | 1 | 2013 | 553 | 0.070 |
Why?
|
| Hypothyroidism | 1 | 2008 | 78 | 0.060 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2010 | 363 | 0.060 |
Why?
|
| Ovarian Neoplasms | 1 | 2011 | 455 | 0.060 |
Why?
|
| Muscle Cells | 1 | 2006 | 25 | 0.060 |
Why?
|
| Intestine, Small | 1 | 2009 | 286 | 0.060 |
Why?
|
| Immunohistochemistry | 2 | 2014 | 1610 | 0.060 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2008 | 180 | 0.060 |
Why?
|
| Necrosis | 1 | 2006 | 194 | 0.060 |
Why?
|
| Acute Kidney Injury | 1 | 2013 | 685 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2014 | 1956 | 0.060 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2010 | 551 | 0.060 |
Why?
|
| Fatal Outcome | 1 | 2006 | 364 | 0.060 |
Why?
|
| Diagnosis, Differential | 3 | 2017 | 1910 | 0.060 |
Why?
|
| Repressor Proteins | 1 | 2010 | 777 | 0.060 |
Why?
|
| Vinblastine | 1 | 2025 | 55 | 0.060 |
Why?
|
| Antigens, CD1 | 1 | 2004 | 23 | 0.060 |
Why?
|
| Brain Neoplasms | 1 | 2014 | 1297 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2014 | 2436 | 0.050 |
Why?
|
| Hodgkin Disease | 1 | 2007 | 312 | 0.050 |
Why?
|
| Eosinophils | 2 | 2016 | 126 | 0.050 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2011 | 849 | 0.050 |
Why?
|
| Infant Formula | 1 | 2004 | 104 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2007 | 1487 | 0.050 |
Why?
|
| Ethanol | 1 | 2004 | 164 | 0.050 |
Why?
|
| Esophagus | 2 | 2016 | 237 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2004 | 418 | 0.050 |
Why?
|
| Prognosis | 2 | 2015 | 4951 | 0.050 |
Why?
|
| Retrospective Studies | 4 | 2021 | 17648 | 0.050 |
Why?
|
| Endoscopy | 1 | 2024 | 282 | 0.040 |
Why?
|
| HIV Infections | 1 | 2013 | 2037 | 0.040 |
Why?
|
| Biopsy | 2 | 2015 | 1249 | 0.040 |
Why?
|
| Disease Progression | 1 | 2007 | 2205 | 0.040 |
Why?
|
| Feces | 1 | 2024 | 725 | 0.040 |
Why?
|
| Ultrasonography | 2 | 2017 | 972 | 0.040 |
Why?
|
| Skin | 2 | 2014 | 553 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 2143 | 0.040 |
Why?
|
| Infant, Premature | 1 | 2025 | 856 | 0.040 |
Why?
|
| Young Adult | 4 | 2015 | 10092 | 0.040 |
Why?
|
| Mice | 4 | 2016 | 18473 | 0.030 |
Why?
|
| Rheumatic Diseases | 1 | 2017 | 78 | 0.030 |
Why?
|
| Janus Kinase 3 | 1 | 2016 | 16 | 0.030 |
Why?
|
| Chloroquine | 1 | 2016 | 31 | 0.030 |
Why?
|
| Philadelphia Chromosome | 1 | 2016 | 43 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 2013 | 1008 | 0.030 |
Why?
|
| Keratinocytes | 1 | 2016 | 74 | 0.030 |
Why?
|
| STAT5 Transcription Factor | 1 | 2016 | 86 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2008 | 2646 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2016 | 3861 | 0.030 |
Why?
|
| Epithelium | 1 | 2016 | 343 | 0.030 |
Why?
|
| Pennsylvania | 1 | 2015 | 61 | 0.030 |
Why?
|
| Esophagoscopy | 1 | 2016 | 174 | 0.030 |
Why?
|
| Asperger Syndrome | 1 | 2014 | 8 | 0.030 |
Why?
|
| Lipomatosis | 1 | 2014 | 15 | 0.030 |
Why?
|
| SMARCB1 Protein | 1 | 2014 | 42 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 344 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 1235 | 0.030 |
Why?
|
| Models, Animal | 1 | 2016 | 459 | 0.030 |
Why?
|
| Hematuria | 1 | 2014 | 48 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 428 | 0.030 |
Why?
|
| Africa South of the Sahara | 1 | 2013 | 120 | 0.020 |
Why?
|
| Emigration and Immigration | 1 | 2013 | 81 | 0.020 |
Why?
|
| Neutralization Tests | 1 | 2013 | 226 | 0.020 |
Why?
|
| Animals | 4 | 2016 | 34341 | 0.020 |
Why?
|
| Biomarkers, Tumor | 2 | 2014 | 1617 | 0.020 |
Why?
|
| Laminectomy | 1 | 2012 | 24 | 0.020 |
Why?
|
| Radiography | 1 | 2014 | 760 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 634 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 2014 | 372 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2016 | 739 | 0.020 |
Why?
|
| Lumbar Vertebrae | 1 | 2012 | 109 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2016 | 804 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2013 | 1022 | 0.020 |
Why?
|
| Infliximab | 1 | 2011 | 66 | 0.020 |
Why?
|
| Spinal Fusion | 1 | 2012 | 118 | 0.020 |
Why?
|
| Eyelid Diseases | 1 | 2011 | 58 | 0.020 |
Why?
|
| Oculomotor Muscles | 1 | 2011 | 81 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2010 | 32 | 0.020 |
Why?
|
| Edema | 1 | 2011 | 139 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 2015 | 794 | 0.020 |
Why?
|
| Consanguinity | 1 | 2010 | 119 | 0.020 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2010 | 103 | 0.020 |
Why?
|
| Mutation | 2 | 2016 | 6177 | 0.020 |
Why?
|
| Aged | 1 | 2008 | 21238 | 0.020 |
Why?
|
| Mutagenesis, Insertional | 1 | 2010 | 152 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 2297 | 0.020 |
Why?
|
| Adult | 3 | 2015 | 31666 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 3672 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2016 | 1614 | 0.020 |
Why?
|
| Homozygote | 1 | 2010 | 547 | 0.020 |
Why?
|
| Visual Acuity | 1 | 2011 | 537 | 0.020 |
Why?
|
| Abnormalities, Multiple | 1 | 2013 | 974 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 1276 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2011 | 1168 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2010 | 1069 | 0.020 |
Why?
|
| Syndrome | 1 | 2010 | 1166 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 1356 | 0.020 |
Why?
|
| Pedigree | 1 | 2010 | 1710 | 0.020 |
Why?
|
| United States | 2 | 2013 | 11794 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2010 | 2562 | 0.010 |
Why?
|
| Base Sequence | 1 | 2010 | 2782 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 3614 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2007 | 909 | 0.010 |
Why?
|
| Developmental Disabilities | 1 | 2010 | 760 | 0.010 |
Why?
|
| DNA | 1 | 2010 | 1443 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 1809 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2013 | 4763 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2007 | 1258 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2007 | 1322 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 2116 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 5277 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 4684 | 0.010 |
Why?
|
| Middle Aged | 2 | 2015 | 28839 | 0.010 |
Why?
|
| Phenotype | 1 | 2010 | 4517 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2007 | 12936 | 0.010 |
Why?
|